12:35 PM EST - Delivra Corp. : Announced the ability to treat pain directly with a topical version of Advil™ (ibuprofen). Testing for effects on joint pain and inflammation, topical Delivra-ibuprofen formulation offers long-term pain and swelling reduction compared to oral ibuprofen. Delivra Corp.
shares V.DVA are trading up $0.015 at $0.37.
